Mapping the platelet profile for functional genomic studies and demonstration of the effect size of the GP6 locus
暂无分享,去创建一个
A H Goodall | C Berzuini | P Burns | C. Berzuini | W. Ouwehand | B. Tom | F. Dudbridge | J. Stephens | A. Goodall | S. Garner | A. Rankin | R. Farndale | C. Berzuini | W. Angenent | P. Burns | R W Farndale | C. Jones | J Hogwood | A. Bernard | J. Hogwood | J. Walton | F Dudbridge | W H Ouwehand | C I Jones | S F Garner | W Angenent | A Bernard | A Rankin | J C Stephens | B D Tom | J Walton | J. Stephens | B. Tom | Brian D. M. Tom | Philippa Burns
[1] François Mach,et al. Inflammation and Atherosclerosis , 2004, Herz.
[2] P. Fontana,et al. Adenosine Diphosphate–Induced Platelet Aggregation Is Associated With P2Y12 Gene Sequence Variations in Healthy Subjects , 2003, Circulation.
[3] F. Gries,et al. Platelet Membrane Activation Markers Are Predictive for Increased Risk of Acute Ischemic Events After PTCA , 1993, Circulation.
[4] Z. Ruggeri,et al. Von Willebrand factor, platelets and endothelial cell interactions , 2003, Journal of thrombosis and haemostasis : JTH.
[5] W. Ouwehand,et al. The low-frequency allele of the platelet collagen signaling receptor glycoprotein VI is associated with reduced functional responses and expression. , 2003, Blood.
[6] J. Erikssen,et al. Blood Platelet Count and Function Are Related to Total and Cardiovascular Death in Apparently Healthy Men , 1991, Circulation.
[7] A. Beckett,et al. AKUFO AND IBARAPA. , 1965, Lancet.
[8] C. Gachet,et al. The P2 receptors in platelet function. , 2005, Seminars in thrombosis and hemostasis.
[9] N. Arber,et al. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. , 1990, The New England journal of medicine.
[10] Jonathan C. Cohen,et al. Multiple Rare Alleles Contribute to Low Plasma Levels of HDL Cholesterol , 2004, Science.
[11] T. Kunicki. The Influence of Platelet Collagen Receptor Polymorphisms in Hemostasis and Thrombotic Disease , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[12] P. Bray,et al. Aggregometry detects platelet hyperreactivity in healthy individuals. , 2005, Blood.
[13] G. FitzGerald. Mechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonists. , 1991, The American journal of cardiology.
[14] W. Ouwehand,et al. Definition of novel GP6 polymorphisms and major difference in haplotype frequencies between populations by a combination of in‐depth exon resequencing and genotyping with tag single nucleotide polymorphisms , 2006, Journal of thrombosis and haemostasis : JTH.
[15] M. Hoylaerts,et al. The platelet ATP and ADP receptors. , 2006, Current pharmaceutical design.
[16] N. Samani,et al. Dimorphism in the P2Y1 ADP Receptor Gene Is Associated With Increased Platelet Activation Response to ADP , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[17] R H Myers,et al. Genetic and Environmental Contributions to Platelet Aggregation: The Framingham Heart Study , 2001, Circulation.
[18] P. Perrotta,et al. Transcript profiling of human platelets using microarray and serial analysis of gene expression. , 2003, Blood.
[19] A. Goodall,et al. ADP causes partial degranulation of platelets in the absence of aggregation , 1994, British journal of haematology.
[20] P. Mannucci,et al. Released adenosine diphosphate stabilizes thrombin-induced human platelet aggregates. , 1990, Blood.
[21] R. Young,et al. Integrin alpha 2 beta 1-independent activation of platelets by simple collagen-like peptides: collagen tertiary (triple-helical) and quaternary (polymeric) structures are sufficient alone for alpha 2 beta 1-independent platelet reactivity. , 1995, The Biochemical journal.
[22] M. Hughes,et al. Adjusting for regression toward the mean when variables are normally distributed , 1997, Statistical methods in medical research.
[23] P. Propping,et al. Epinephrine‐induced platelet aggregation. A twin study ** , 1984, Clinical genetics.
[24] S. Bernocco,et al. Early Events in the Polymerization of Fibrin , 2001, Annals of the New York Academy of Sciences.
[25] A. Mattioli,et al. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.
[26] D. Monroe,et al. A Cell-based Model of Hemostasis , 2001, Thrombosis and Haemostasis.
[27] D. Altman,et al. STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.
[28] L Roy,et al. Platelet activation in unstable coronary disease. , 1986, The New England journal of medicine.
[29] Peter Bugert,et al. Messenger RNA profiling of human platelets by microarray hybridization , 2003, Thrombosis and Haemostasis.
[30] W. Ouwehand,et al. Comparative gene expression profiling of in vitro differentiated megakaryocytes and erythroblasts identifies novel activatory and inhibitory platelet membrane proteins. , 2007, Blood.
[31] Fred Charatan. US doctors win round in battle for right to negotiate with HMOs , 2000, BMJ : British Medical Journal.
[32] P. Libby,et al. Inflammation and Atherosclerosis , 2002, Circulation.
[33] Catherine Sudlow,et al. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.
[34] E. Mammen,et al. Circadian variation in platelet function in healthy volunteers. , 1992, The American journal of cardiology.
[35] M. Dalby,et al. Diurnal variation in platelet aggregation iwth the PFA-100 platelet function analyser. , 2000, Platelets.
[36] L. Lin,et al. A concordance correlation coefficient to evaluate reproducibility. , 1989, Biometrics.
[37] M.C.D. Dalby, S.J. Davidson, J.F. Burman, S.W. Davies. Diurnal variation in platelet aggregation with the PFA–100 platelet function analyser , 2000 .
[38] O. McCarty,et al. GPVI and integrin αIIbβ3 signaling in platelets , 2005, Journal of thrombosis and haemostasis : JTH.
[39] W. Ouwehand,et al. Platelet genomics and proteomics in human health and disease. , 2005, The Journal of clinical investigation.